A detailed history of Vanguard Group Inc transactions in Ikena Oncology, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,384,664 shares of IKNA stock, worth $2.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,384,664
Previous 1,364,470 1.48%
Holding current value
$2.4 Million
Previous $2.25 Million 6.4%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$1.6 - $1.85 $32,310 - $37,358
20,194 Added 1.48%
1,384,664 $2.4 Million
Q2 2024

Aug 13, 2024

SELL
$1.24 - $1.82 $207,946 - $305,212
-167,699 Reduced 10.95%
1,364,470 $2.25 Million
Q1 2024

May 10, 2024

BUY
$1.27 - $2.0 $9,297 - $14,642
7,321 Added 0.48%
1,532,169 $2.18 Million
Q4 2023

Feb 14, 2024

BUY
$1.33 - $4.4 $228,579 - $756,201
171,864 Added 12.7%
1,524,848 $3 Million
Q3 2023

Nov 14, 2023

BUY
$4.09 - $6.43 $1.05 Million - $1.66 Million
257,814 Added 23.54%
1,352,984 $5.86 Million
Q2 2023

Aug 14, 2023

BUY
$3.5 - $7.31 $338,037 - $706,014
96,582 Added 9.67%
1,095,170 $7.18 Million
Q1 2023

May 15, 2023

BUY
$2.62 - $4.97 $49,966 - $94,782
19,071 Added 1.95%
998,588 $3.45 Million
Q4 2022

Feb 10, 2023

BUY
$2.0 - $3.7 $1,028 - $1,901
514 Added 0.05%
979,517 $2.61 Million
Q3 2022

Nov 14, 2022

BUY
$3.46 - $6.0 $1.05 Million - $1.83 Million
304,898 Added 45.23%
979,003 $3.48 Million
Q2 2022

Aug 12, 2022

SELL
$3.23 - $7.4 $374,337 - $857,615
-115,894 Reduced 14.67%
674,105 $2.99 Million
Q1 2022

May 13, 2022

BUY
$5.61 - $13.85 $42,664 - $105,329
7,605 Added 0.97%
789,999 $4.82 Million
Q4 2021

Feb 14, 2022

BUY
$10.52 - $16.96 $1.7 Million - $2.74 Million
161,708 Added 26.05%
782,394 $9.81 Million
Q3 2021

Nov 12, 2021

BUY
$9.82 - $15.23 $2.87 Million - $4.45 Million
292,074 Added 88.88%
620,686 $7.83 Million
Q2 2021

Aug 13, 2021

BUY
$13.27 - $26.0 $4.36 Million - $8.54 Million
328,612 New
328,612 $4.61 Million

Others Institutions Holding IKNA

About Ikena Oncology, Inc.


  • Ticker IKNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,257,500
  • Market Cap $62.7M
  • Description
  • Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...
More about IKNA
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.